Genolution Inc. (KOSDAQ:225220)
South Korea
· Delayed Price · Currency is KRW
2,240.00
+40.00 (1.82%)
At close: May 8, 2025, 3:30 PM KST
Genolution Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Operating Revenue | 7,136 | 9,761 | 38,085 |
| Other Revenue | -0 | - | -0 |
| Revenue | 7,136 | 9,761 | 38,085 |
| Revenue Growth (YoY) | -26.90% | -74.37% | - |
| Cost of Revenue | 4,836 | 5,304 | 12,177 |
| Gross Profit | 2,300 | 4,457 | 25,907 |
| Selling, General & Admin | 7,940 | 7,142 | 8,660 |
| Research & Development | 1,672 | 3,081 | 1,516 |
| Other Operating Expenses | 252.32 | 330.46 | -18.12 |
| Operating Expenses | 11,464 | 11,549 | 11,171 |
| Operating Income | -9,164 | -7,091 | 14,737 |
| Interest Expense | -418.09 | - | -311.61 |
| Interest & Investment Income | 1,808 | 1,835 | 665.52 |
| Earnings From Equity Investments | -103.43 | 382.21 | -144.85 |
| Currency Exchange Gain (Loss) | 4,114 | 377.64 | 1,703 |
| Other Non Operating Income (Expenses) | 126.9 | 19.02 | 568.26 |
| EBT Excluding Unusual Items | -3,637 | -4,477 | 17,217 |
| Gain (Loss) on Sale of Investments | -3,118 | 542.13 | -459.01 |
| Gain (Loss) on Sale of Assets | - | -2,577 | 218.54 |
| Asset Writedown | -17 | -141.55 | - |
| Other Unusual Items | - | - | 262.4 |
| Pretax Income | -6,771 | -6,653 | 17,239 |
| Income Tax Expense | 437.36 | -1,103 | 2,637 |
| Earnings From Continuing Operations | -7,209 | -5,550 | 14,602 |
| Minority Interest in Earnings | 383.22 | 38.75 | - |
| Net Income | -6,826 | -5,512 | 14,602 |
| Net Income to Common | -6,826 | -5,512 | 14,602 |
| Shares Outstanding (Basic) | 18 | 18 | 18 |
| Shares Outstanding (Diluted) | 18 | 18 | 19 |
| Shares Change (YoY) | -1.71% | -3.24% | - |
| EPS (Basic) | -378.00 | -300.00 | 801.00 |
| EPS (Diluted) | -378.00 | -300.00 | 769.00 |
| Free Cash Flow | -13,558 | -7,940 | -8,955 |
| Free Cash Flow Per Share | -750.83 | -432.18 | -471.59 |
| Gross Margin | 32.23% | 45.66% | 68.03% |
| Operating Margin | -128.42% | -72.65% | 38.70% |
| Profit Margin | -95.65% | -56.46% | 38.34% |
| Free Cash Flow Margin | -190.00% | -81.34% | -23.51% |
| EBITDA | -7,123 | -5,513 | 16,065 |
| EBITDA Margin | -99.82% | -56.48% | 42.18% |
| D&A For EBITDA | 2,041 | 1,578 | 1,328 |
| EBIT | -9,164 | -7,091 | 14,737 |
| EBIT Margin | -128.42% | -72.65% | 38.70% |
| Effective Tax Rate | - | - | 15.30% |
| Advertising Expenses | 470.47 | 343.49 | 435.03 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.